Pay in 4 interest-free payments of $10.00 Learn more
Ships within 48 hours · Estimated delivery Aug 24 - Aug 29
which are required for MLL1 mediated leukemogenesis
Molecular Weight: 244
28)29)18-6-4-16(5-7-18)17-8-10-19(11-9-17)36(3
Abstract 1045
is a potent and selective small molecule activator of human TRPA1
ATB-346 - CAS# 1226895-20-0 Catalog No.:M60414-2S which are required for MLL1ATB 346, CAS No. 1226895 20 0, is anti inflammatory agent, which is structurally an analogue of naproxen. ABT 346 exhibits anti inflammatory properties similar to naproxen, but with substantially reduced gastrointestinal toxicity. ATB 346 suppressed colonic prostaglandin synthesis and whole blood thromboxane synthesis as effectively as naproxen, but did not induce any gastrointestinal injury. ATB 346 exerts superior chemopreventive effects to those of